InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Sebree Terri B, Présidente. Director active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 2 disclosures have been recorded. The latest transaction was filed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
085,000 shares0
Common Stock
SEC:0001062993-22-001778·
085,000 shares0
Common Stock
SEC:0001062993-22-001778:0·
2 of 2 declarations
About Sebree Terri B
Terri B. Sebree is the President of Zynerba Pharmaceuticals, Inc. In this role, she oversees the company's operations and is responsible for implementing the business strategy. Sebree plays a key role in directing and managing activities, ensuring that Zynerba meets its business objectives. Her experience in the pharmaceutical sector contributes to the organization's success.
